Objective: No study has investigated the frequency and risk factors for deficit schizophrenia (DS) in Chinese Han population. We investigated the prevalence of DS among community-dwelling older Chinese patients with schizophrenia and examined the sociodemographic and clinical correlates of DS in this population. Methods: A total of 326 community-dwelling older patients with schizophrenia were recruited in this cross-sectional study. Deficit schizophrenia was confirmed using the Chinese version of the Schedule for the Deficit Syndrome. Data pertaining to sociodemographic and clinical characteristics were collected. Psychopathology was assessed using the Positive and Negative Syndrome Scale (PANSS). Results: The prevalence of DS in the study population was 26.7% (31.2% among male patients and 21.6% among female patients with schizophrenia). Patients with DS had significantly higher current smoking rate, hospitalizations, PANSS negative score, PANSS total score, and had earlier age at onset than patients with non-deficit schizophrenia (N-DS). The N-DS patients had higher PANSS positive scores and a greater proportion of married patients. Multiple logistic regression analysis indicated that negative PANSS score (odds ratio [OR] ¼ 1.10, 95% confidence interval [CI] ¼ 1.04-1.16, P < .001), male sex (OR ¼ 1.71, 95% CI ¼ 1.53-1.91, P ¼ .037), age at onset (OR ¼ 0.88, 95% CI ¼ 0.82-0.94, P ¼ .035), and current smoking (OR ¼ 1.37, 95% CI ¼ 1.15-1.63, P ¼ .041) were independently associated with DS. Conclusion: Deficit schizophrenia is relatively common among older community-dwelling Chinese patients with schizophrenia. High negative symptom scores, male sex, early onset, and smoking were independent correlates for DS.
Introduction
Schizophrenia is a heterogeneous psychiatric disorder with imprecise diagnostic boundaries. 1 Deficit schizophrenia (DS) is a pathophysiologically and symptomatologically distinct subgroup of schizophrenia that is characterized by primary, prominent negative symptoms. 2 Conceptually, primary and enduring negative symptoms in patients with DS are not secondary to other disease-related factors such as anxiety, depression, positive symptoms, medication side effects, mental retardation, substance abuse, or environmental deprivation. 3 The validity of the diagnosis of DS has been confirmed by several studies. 4, 5 Patients with DS differ from non-deficit schizophrenia (N-DS) in several aspects such as remarkably evident negative symptoms, a greater propensity for occurrence in males, early disease onset, worse treatment response, greater cognitive impairment, poorer long-term clinical outcomes, and more severe neurofunctional abnormalities. 6, 7 Several studies have focused on the sociodemographic and clinical differences between patients with DS and N-DS patients. Patients born in summer season showed a significant association with DS, while those born in winter season showed an association with N-DS. 8 Emerging evidence indicates that DS has distinctive clinical features with enduring, idiopathic negative symptoms but a slightly lower severity of psychotic symptoms. 9 However, in some studies, patients with DS showed more severe positive symptoms. 10 Other studies have shown inconsistent results pertaining to differences between patients with DS and N-DS patients with respect to risk factors such as sex and family history of mental illness. 11, 12 In previous studies, approximately 15% of patients with first-episode schizophrenia and 25% to 30% of patients with chronic schizophrenia qualified the diagnostic criteria for DS. 1, 3 The prevalence of DS has been shown to be associated with racial, biological, psychological, social, and cultural factors. [13] [14] [15] The prevalence of deficit syndrome among community-dwelling older Chinese patients with schizophrenia has not been investigated till date. Characterization of DS and its risk factors in this population may provide valuable insights. The aim of this study was to investigate the prevalence of DS among older patients with schizophrenia in a Chinese Han population and to characterize the sociodemographic and clinical correlates of DS in this population.
Methods Participants
This cross-sectional study recruited all community-dwelling patients with schizophrenia who participated in the community management and services program for psychosis in Yuhuatai district of Nanjing from May 01, 2016, to August 31, 2017. The study was approved by the institutional ethical committee for clinical research of the Nanjing Meishan Hospital and the institutional review board of the Nanjing Department of Health. Written informed consent was obtained from all participants prior to their enrollment.
In China, the cutoff age for older adults is 60 years, which is different from the criterion (65 years) used in most other countries. 16 Only patients who qualified the following criteria were recruited: (1) Han Chinese individuals aged !60 years; (2) patients with confirmed diagnosis of schizophrenia according to the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition 17 ; and (3) participants in the community management program for severe psychosis 18 who had resided locally for at least 1 year. An annual free complete checkup including physical examination and laboratory tests is provided to patients who are registered and managed in the community management program. The exclusion criteria were patients with neurological disorders, severe comorbid conditions, mental retardation, head trauma, alcoholism, or substance abuse disorder.
A total of 326 older patients (173 males and 153 females) were included in the study. Data pertaining to age, sex, educational level, marital status, current smoking status, and other sociodemographic variables were collected using a questionnaire. The following information pertaining to medical conditions was obtained from family members, treating clinicians, and medical records: age at onset, duration of illness, type of antipsychotic medication, concomitant medications, and number of hospitalizations. Patients born in the months of June, July, or August were considered born in summer season.
Evaluation of DS
Primary DS was identified by 2 psychiatrists according to the validated Chinese version of the Schedule for Deficit Syndrome (SDS). 19 The criteria for diagnosis included presence of at least 2 of the following 6 symptoms (restricted affect, diminished emotional range, poverty of speech, curbing of interests, diminished sense of purpose, and diminished social drive), persistence of moderate-severe symptoms for at least 12 months, and symptoms not attributed to secondary sources such as extrapyramidal side effects, paranoia, depression, or anxiety. Assessments performed by the 2 psychiatrists using the SDS showed good interobserver reliability (intraclass correlation coefficient: 0.87).
Clinical Measurement
Two psychiatrists independently assessed the symptoms of all patients using the 30-item Positive and Negative Syndrome Scale (PANSS) 20 ; both psychiatrists had received training at the same time. The PANSS consists of 3 factors: positive factors (P1-P7), negative factors (N1-N7), and general psychopathology factors (G1-G16). The intraclass correlation coefficient for the PANSS total score was 0.82.
Statistical Analysis
The continuous variables were normally distributed as assessed by the 1-sample Kolmogorov-Smirnov test (P > .05 for all). Between-group differences with respect to continuous variables (demographic and clinical) were assessed using independent samples t test, and those with respect to categorical variables were assessed using the w 2 test. Binary logistic forward stepwise regression analysis was conducted to identify factors that were significantly associated with DS after controlling for variables that showed a significant between-group difference in univariate analysis. Variables including age, sex, marital status, current smoking, hospitalization times, age at onset, and subscale and total PANSS scores were entered as potential correlates of DS. Considering that the negative symptoms contributed greatly to DS in the logistic regression, it may cover the contribution of other variables. 21 We removed the negative symptoms and performed a logistic regression again with the "Enter" method. Data were analyzed using SPSS version 21.0 for Windows; P values < .05 (2-tailed) were considered indicative of statistical significance.
Results

Demographic Characteristics of All Patients
A total of 326 community-dwelling older patients with schizophrenia were enrolled in Nanjing, China ( Table 1 ). The mean age of patients was 68.6 + 7.8 years; 173 (53.1%) patients were male. Sixty-five (19.9%) patients were illiterate, 120 (36.8%) had primary school education, 91 (27.9%) had junior middle school education, and 50 (15.3%) were educated up to high school or higher level. The number of married and unmarried patients was 195 (59.8%) and 131 (40.2%), respectively. The mean age at onset was 35.6 + 14.3 years; mean number of hospitalizations was 2.7 + 1.6. Antipsychotic drugs were used by 221 (67.8%) patients. The number of patients receiving monotherapy with typical and atypical antipsychotics was 44 (13.5%) and 159 (48.8%), respectively; 18 (5.5%) patients were receiving typical antipsychotics in combination with atypical antipsychotics. Twenty-seven (8.3%) patients had anticholinergic exposure. The mean chlorpromazine equivalent dose was 322.3 + 177.5 mg/d. The current smoking rate was 101 (31.0%). The mean total PANSS score for the study population was 81.4 + 17.7; the positive score of PANSS was 21.7 + 5.6, the negative score of PANSS was 23.7 + 7.2, and the general psychopathology score of PANSS was 37.5 + 9.4.
Comparison of Demographic and Clinical Variables Between Deficit and Non-DS
There were no significant differences between patients with DS and N-DS with respect to age (t ¼ À0.587, P ¼ .714) or education level (w 2 ¼ 2.005, P ¼ .571). The percentage of married patients in the DS group was significantly lower than that in the N-DS group (48.3% vs 64.0%, respectively; w 2 ¼ 6.575, P ¼ .010). The current smoking rate was 40.2% and 27.6%, respectively (w 2 ¼ 4.747, P ¼ .029); the proportion of male patients in the DS group was significantly greater than that in the N-DS group (w 2 ¼ 1.478, p ¼ 0.224). The mean number of hospitalizations in the DS group was significantly greater than that in the N-DS group (4.1 + 2.8 vs 2.2 + 1.1, t ¼ 2.590, P ¼ 0.021). The age at onset in the N-DS group was significantly greater than that in the DS group (36.8 + 15.2 vs 31.9 + 12.3, t ¼ 3.107, P ¼ .033). There was no significant between-group difference with respect to employment status or usage of antipsychotics and anticholinergic drugs (P > .05 for all).
Patients with DS had significantly higher negative score (31.4 + 10.1 vs 18.9 + 6.5, t ¼ 12.771, P < .001) and total PANSS score (88. respect to general psychopathology score and chlorpromazine equivalent dose (P > .05 for both). 
Prevalence and Risk Factors for DS
Discussion
To the best of our knowledge, this was the first study to explore the frequency as well as the associated sociodemographic and clinical correlates of schizophrenia among older Chinese community-dwelling patients. In this study, DS showed a significant association with higher current smoking rate, hospitalization, PANSS negative scores, and total scores. Patients with N-DS had higher positive scores, greater percentage of married patients, and higher age of onset. Of note, male sex, age at onset, current smoking status, and PANSS negative score were independent correlates for DS among older patients with schizoprenia.
In our study, the prevalence of DS (26.7%) among older Chinese patients with schizophrenia was higher than that reported by Kirkpatrick et al (15%) 1 but lower than that reported from a more recent study (32.6%). 22 There may be some explanations for this difference. Previous studies included hospitalized patients with schizophrenia, while our study enrolled only community-dwelling patients with schizophrenia registered with a community-based program for management of severe psychiatric disorders and did not include psychiatric inpatients. In addition, the age of our patients was older and the educational level was lower. This may have led to inconsistent results.
In our study, the prevalence of DS among male patients with schizophrenia was higher than that among female patients, which is consistent with the results of previous studies. 11, 23 This phenomenon may be attributable to 2 factors. Estrogens were shown to have a protective effect against schizophrenia and to decrease the severity of schizophrenia in premenopausal women. 24 A second explanation would be that schizophrenia includes subgroups of patients with different etiology, and these subgroups exhibit different sex predilection. 25 Males may be more likely than females to develop severe/neurodevelopmental schizophrenia characterized by a family history of schizophrenia. 26 Conflicting results have been reported pertaining to the relationship between schizophrenia and current smoking. In our study, patients with DS had significantly higher rates of smoking (40.2%) than patients with N-DS (27.6%), and we did find a significant association between cigarette smoking and DS. In addition, patients with DS had more negative symptoms and less positive symptoms. Numerous studies have suggested that the high smoking rate in schizophrenia may be due to the reduction of side effects of antipsychotic drugs and negative symptoms. 27, 28 This finding is consistent with a previous study on schizophrenia in Western setting but was not consistent with others. 29, 30 Further studies are required to explore the relationship between smoking and psychiatric symptoms in the 2 groups. Our results confirmed the association between negative symptoms and DS, which may be induced by abnormalities in brain regions and neuroanatomic differences. 13, 31 The association of age at onset with DS is well-documented; however, 2 studies found no significant difference between patients with DS and N-DS patients in this respect. 32 In another study, the age at onset among male patients was lower than that among female patients. 33 In the present study, the age at onset in patients with DS was lower than that among N-DS patients. This may be potentially associated with neuropathological damage. In a previous study, as compared to N-DS, patients with DS showed higher scores on the Childhood Behavior Checklist subscale "Withdrawn" during childhood. 34 In neuroimaging studies, patients with DS exhibited thinner anterior cingulate gyrus cortex and significantly reduced regional cerebral blood flow in the right orbitofrontal cortex as compared to the nondeficit group. 31, 35 The presence of these aspects since childhood in patients with DS supports the hypothesis that they represented a schizophrenia endophenotype.
Our research has several limitations. First, this was a crosssectional study and the direct causality of relationship between deficit syndrome and other variables cannot be concluded. Longitudinal studies are required to draw more definitive conclusions. Second, only community-dwelling patients in a single district of Nanjing were enrolled in this study. Therefore, our findings may not be applicable to other regions in China. Third, it is well known that deficit syndrome is associated with several endocrinal and metabolic factors. We did not assess these factors and did not perform functional brain imaging. Fourth, our study did not include a sex-and age-matched healthy control group, which made it difficult to draw definitive conclusions. In summary, DS is relatively common among Chinese older patients with schizophrenia and exhibits a strong association with negative symptoms; these characteristics are consistent with those reported from Western settings. Further studies with larger sample size and inclusion of inpatients with schizophrenia would help clarify the relationship between DS and sociodemographic and clinical variables.
